Pfizer has formally asked the FDA to authorize emergency use of its COVID-19 vaccine for children ages 5 to 11. If authorized, this would be the first COVID vaccine for that age group and could help protect roughly 28 million young kids across the country. The FDA has scheduled a meeting with an independent advisory committee on October 26th to consider Pfizer's request. Dr. Christina Johns, senior medical advisor of PM pediatrics, tells Cheddar why she expects the FDA to give the green light and what it could mean for the path of the pandemic.